# REN-01 Simulation Methodology and Results Report

**Date:** January 19, 2026  
**Author:** Christopher Ezernack  
**Status:** PRELIMINARY - Requires Real Data Integration

---

## Executive Summary

This report documents the mathematical implementation, simulation methodology, and preliminary results for the REN-01 quaternionic entropy field model. **IMPORTANT:** The current simulations use synthetic parameters based on the mathematical framework. Real experimental data from OpenNeuro (ds000245) and PubChem (CID 66553195) must be integrated for validation.

---

## 1. Mathematical Framework Implementation

### 1.1 Core Quaternionic PDE

The simulation implements the following quaternionic field equation from the manuscript:

```
∂Q/∂t = D_Q ∇²Q - β_E φ_E(Q^n) i Q + α_D ψ_D j Q + α_A A k Q + η_Q(x,t)
```

Where:
- **Q** = q₀ + q₁i + q₂j + q₃k is a unit quaternion field (constrained to S³)
- **φ_E** = q₁² + q₃² is the entropy projection
- **ψ_D** = q₀² is the dopaminergic projection
- **A** represents astrocytic activity (CB2-mediated)
- **η_Q** is stochastic Gaussian noise

### 1.2 Numerical Parameters Used

**WARNING: These are synthetic parameters, not derived from real data**

| Parameter | Value | Physical Meaning |
|-----------|-------|------------------|
| D_Q | 0.01 | Quaternion diffusion coefficient |
| β_E | 0.5 | Entropy feedback strength |
| α_D | 0.3 | Dopaminergic coupling |
| α_A | 0.2 | Astrocytic coupling |
| σ_noise | 0.05 | Stochastic noise amplitude |
| dt | 0.02 | Time step |
| T_total | 40.0 | Total simulation time |
| N_steps | 2000 | Number of time steps |

### 1.3 Scenario Definitions

**Healthy Scenario:**
- Initial condition: Q = (0.7, 0.5, 0.3, 0.4) (normalized)
- Full coupling: β_E = 0.5, α_D = 0.3, α_A = 0.2
- Low noise: σ = 0.05

**Degenerative Scenario:**
- Initial condition: Q = (0.5, 0.6, 0.4, 0.5) (normalized)
- Reduced dopamine: α_D = 0.1 (67% reduction)
- Reduced astrocyte: α_A = 0.05 (75% reduction)
- Increased entropy feedback: β_E = 0.8
- High noise: σ = 0.15

**REN-01 Treatment Scenario:**
- Starts from degenerative state
- Restored dopamine: α_D = 0.25 (MOR agonism)
- Enhanced astrocyte: α_A = 0.3 (CB2 activation)
- Normalized entropy: β_E = 0.5
- Moderate noise: σ = 0.08

---

## 2. Collapse Metric Definition

The collapse metric χ quantifies regime stability:

```
χ(t) = ||∇φ_E||² + ||∇ψ_D||² + λ|φ_E - φ_E,target|
```

Where:
- λ = 1.0 is the target deviation penalty
- φ_E,target = 0.3 (healthy entropy level)
- Lower χ indicates higher collapse risk
- Higher χ indicates maintained regime stability

---

## 3. Simulation Results

### 3.1 Final Collapse Metrics

| Scenario | Final χ | Interpretation |
|----------|---------|----------------|
| Healthy | 5.17 | Stable, moderate entropy |
| Degenerative | 0.92 | **Critical collapse risk** |
| REN-01 | 6.90 | **Restored stability** |

### 3.2 Key Findings

1. **Degenerative Collapse:** The degenerative scenario shows χ → 0.92, indicating severe regime instability consistent with Parkinsonian entropy collapse.

2. **REN-01 Restoration:** Treatment scenario achieves χ = 6.90, **exceeding healthy baseline** (5.17), suggesting over-compensation or enhanced resilience.

3. **Temporal Dynamics:** 
   - Healthy: Oscillatory but stable (χ ranges 5-24)
   - Degenerative: Monotonic decline (χ: 3.7 → 0.9)
   - REN-01: Recovery trajectory (χ: 5.0 → 6.9)

---

## 4. Generated Figures

All figures were generated from simulation data and saved to `/home/ubuntu/REN-01/figures/`:

1. **quaternion_components_healthy.png** - Time evolution of q₀, q₁, q₂, q₃ in healthy state
2. **quaternion_components_ren01.png** - Time evolution under REN-01 treatment
3. **algebraic_chain_trajectories.png** - 3D phase space (q₁, q₂, q₃) for all scenarios
4. **coherence_order_parameter.png** - Quaternion coherence over time
5. **quaternion_attractor.png** - Attractor dynamics in quaternion space
6. **entropy_field_degenerative.png** - Entropy field φ_E in degenerative state
7. **dopamine_field_ren01.png** - Dopamine field ψ_D under treatment
8. **collapse_metric_field_final.png** - Spatial collapse metric χ(x,y)
9. **entropy_dopamine_vector_field_final.png** - Coupled (φ_E, ψ_D) vector field
10. **collapse_metric_comparison.png** - χ(t) for all three scenarios
11. **patient_trajectory.png** - Hypothetical patient progression
12. **astrocyte_field_ren01.png** - Astrocytic activity field A(x,y)

---

## 5. Critical Limitations (MUST ADDRESS)

### 5.1 Synthetic Parameters
**Problem:** All parameters (D_Q, β_E, α_D, α_A, σ) are theoretical estimates, not derived from experimental data.

**Solution Required:**
- Download OpenNeuro ds000245 (Parkinson's fMRI data)
- Extract entropy measures from real brain imaging
- Fit model parameters to actual patient data
- Validate against clinical outcomes

### 5.2 No Molecular Structure Integration
**Problem:** REN-01 molecular properties (MOR/CB2 binding, PEG linker effects) not incorporated.

**Solution Required:**
- Download PubChem CID 66553195 (TRV130/Oliceridine structure)
- Model receptor binding kinetics
- Incorporate pharmacokinetic parameters
- Link molecular properties to field parameters

### 5.3 Missing Validation Tests
**Problem:** No regime uniqueness test, ablation studies, or sensitivity analysis.

**Solution Required (based on EntPTC methodology):**
- **Regime Uniqueness Test:** Verify that healthy, degenerative, and REN-01 regimes are mathematically distinct attractors
- **Ablation Studies:** Test each component (MOR, CB2, entropy feedback) independently
- **Parameter Sensitivity:** Vary each parameter ±50% and measure χ response
- **Noise Robustness:** Test under varying stochastic conditions

---

## 6. Next Steps

### Phase 1: Data Integration (IN PROGRESS)
1. ✅ Mathematical framework implemented
2. ✅ Preliminary simulations complete
3. ⏳ Download OpenNeuro ds000245 dataset
4. ⏳ Download PubChem molecular data
5. ⏳ Extract real parameters from data

### Phase 2: Validation (PENDING)
1. Examine EntPTC regime uniqueness tests
2. Implement REN-01-specific validation suite
3. Run ablation studies
4. Perform sensitivity analysis

### Phase 3: Manuscript Update (PENDING)
1. Update simulation parameters with real data
2. Regenerate all figures
3. Add validation results section
4. Recompile manuscript

---

## 7. Code Structure

```
REN-01/
├── simulations/
│   ├── quaternion_simulator.py      # Core PDE solver
│   ├── run_all_scenarios.py         # Execute all three scenarios
│   ├── generate_figures.py          # Create manuscript figures
│   └── output/
│       ├── all_scenarios_results.pkl  # Pickled simulation data
│       └── REN01_Simulation_Data.csv  # Tabular results
├── figures/                         # Generated PNG figures (13 total)
└── data/                            # Real datasets (TO BE ADDED)
    ├── openneuro/                   # ds000245 Parkinson's imaging
    └── pubchem/                     # TRV130 molecular structure
```

---

## 8. Reproducibility

To reproduce the simulations:

```bash
cd /home/ubuntu/REN-01/simulations
python3 run_all_scenarios.py
python3 generate_figures.py
```

Output:
- Simulation data: `simulations/output/all_scenarios_results.pkl`
- CSV summary: `simulations/output/REN01_Simulation_Data.csv`
- Figures: `figures/*.png`

---

## 9. Conclusion

The preliminary simulations demonstrate the mathematical feasibility of the REN-01 quaternionic entropy model. The degenerative scenario shows clear collapse (χ → 0.92) while REN-01 treatment restores stability (χ → 6.90). However, **these results are based on synthetic parameters and require validation with real experimental data** from OpenNeuro and PubChem before any clinical claims can be made.

The next critical step is integrating actual Parkinson's neuroimaging data and molecular structure information to ground the model in empirical reality.

---

**Report Status:** DRAFT - Awaiting Real Data Integration  
**Last Updated:** January 19, 2026
